Genetic counselling for hypertrophic cardiomyopathy: are we ready for it?
Hypertrophic cardiomyopathy (HCM) is a dominant genetic disorder of the myocardium associated with dysfunctional contractile proteins. The major risk of HCM is sudden cardiac death, which may occur even in asymptomatic carriers. Causes are highly heterogeneous. Over 140 different mutations in nine s...
Збережено в:
| Опубліковано в:: | Curr Control Trials Cardiovasc Med |
|---|---|
| Автор: | |
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2000
|
| Предмети: | |
| Онлайн доступ: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC59597/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11714407/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/cvm-1-1-041 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|